Ustav Hematologie A krevni Transfuze

At Ustav Hematologie A krevni Transfuze in Prague, clinical research in congenital, hereditary, and neonatal diseases and immune system diseases is focused on neutropenias. These studies are exploring new ways to reduce serious infections and support healthier blood cell counts in people living with chronic neutropenic conditions.

• Improving infection control in chronic neutropenia
• Evaluating effects on absolute neutrophil count
• Testing a new treatment approach for inherited and acquired neutropenic disorders

This research aims to better understand treatment effectiveness and safety for patients with ongoing low neutrophil levels.

The site also conducts trials in neoplasms, with a strong focus on chronic lymphocytic leukemia and small lymphocytic lymphoma. These studies are comparing new treatment combinations with existing standard options to see whether they can improve disease control for patients whose cancer has returned or no longer responds well to therapy.

• Studying treatment options for relapsed and refractory CLL/SLL
• Comparing newer targeted combinations with established therapies
• Assessing progression-free survival and overall treatment benefit

This work is designed to help identify more effective strategies for managing difficult-to-treat blood cancers.

Research at the Oddělení buněčné terapie includes studies in Philadelphia-negative B-cell precursor acute lymphoblastic leukemia among older adults. The trials are examining whether a newer treatment approach can improve survival outcomes while remaining tolerable alongside lower-intensity chemotherapy.

• Evaluating treatment effectiveness in newly diagnosed older patients
• Comparing survival outcomes with current standard care
• Focusing on safety and tolerability in a vulnerable patient group

This area of research is aimed at improving care for older people facing a newly diagnosed aggressive blood cancer.